88 afleveringen

"The Long Run"

Antarctic explorer Ernest Shackleton, if he were alive, would appreciate biotech. Today’s scientific entrepreneurs must be ready for the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina, and resilience, to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

The Long Run with Luke Timmerman HeadStepper Media

    • Wetenschap
    • 4.0 • 1 beoordeling

"The Long Run"

Antarctic explorer Ernest Shackleton, if he were alive, would appreciate biotech. Today’s scientific entrepreneurs must be ready for the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina, and resilience, to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

    Ep90: James Sabry on Partnering Amid Scientific Abundance

    Ep90: James Sabry on Partnering Amid Scientific Abundance

    James Sabry, global head of pharma partnering for Roche, on partnering in a time of scientific abundance.

    • 1 u.
    Ep89: Emily Leproust on DNA Synthesis at Scale

    Ep89: Emily Leproust on DNA Synthesis at Scale

    Emily Leproust, co-founder and CEO of Twist Bioscience, on DNA Synthesis at Scale

    • 1 u. 4 min.
    Ep88: Amy DuRoss on software and logistics for cell and gene therapy

    Ep88: Amy DuRoss on software and logistics for cell and gene therapy

    Amy DuRoss, CEO of Vineti, on software and logistics for cell and gene therapy.

    • 1 u. 4 min.
    Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing

    Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing

    Bob Nelsen of ARCH Venture Partners on long-term trends in biotech investing.

    • 49 min.
    Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease

    Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease

    Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.

    • 1 u. 8 min.
    Ep85: Luhan Yang on CRISPR Editing for Organ Transplants

    Ep85: Luhan Yang on CRISPR Editing for Organ Transplants

    Luhan Yang, CEO of Qihan Bio, on CRISPR editing for organ transplants.

    • 47 min.

Klantrecensies

4.0 van 5
1 beoordeling

1 beoordeling

Top-podcasts in Wetenschap

Luisteraars hebben zich ook geabonneerd op

Meer van HeadStepper Media